Boule Diagnostics appoints Jan Benjaminson as interim CFO

Boule Diagnostics AB has today appointed Jan Benjaminson as interim CFO, effective on February 3rd, 2023. Jan will succeed Annette Colin who will continue as CFO up to and including the same date.

Jan has been active in several listed companies, both as CFO and as a board member. Jan’s most recent position was that of CFO at Nordisk Games, Jan has also served as a board member of Starbreeze Studios and other companies.

“Jan brings with him a great expertise in finance and accounting as well as a broad experience of business development in rapidly evolving industries. Boule is in a phase with several strategic initiatives for growth and innovation, to which Jan will contribute from the get-go.”, comments CEO and Group President, Jesper Söderqvist.

For more information, please contact:
Jesper Söderqvist, CEO and Group President, Boule Diagnostics AB, phone +46 (0)70-689 05 90
Annette Colin, CFO, Boule Diagnostics AB, phone +46 (0)70-319 06 76

About Boule Diagnostics AB (publ)
Boule Diagnostics AB is a global diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics. The company serves hospitals, clinics, laboratories and companies within blood diagnostics, in both human and veterinary hematology. The company operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through distributors, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011.

The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on December 14, 2022.

Boule Diagnostics appoints interim CFO 221214

  • Subscribe to our news